NCT05884008 Risk Evaluation by COronary CTA and Artificial intelliGence Based fuNctIonal analyZing tEchniques - I
| NCT ID | NCT05884008 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ruijin Hospital |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2023-05-01 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a multicenter, retrospective imaging study. The study intends to retrospectively enroll patients with acute myocardial infarction who had received coronary CTA in a certain time-window before this event. All coronary CTA will be analyzed by anatomic, functional and radiomic analysis, assisted by artificial intelligence. The purpose of this study is to establish a coronary artery disease risk stratification system by coronary CTA.
Eligibility Criteria
Inclusion Criteria: * Age between 18-80 years old * Received coronary CT angiography 3 months to 5 years prior to acute coronary myocardial infarction. CCTA identified coronary atherosclerotic plaques with diameter stenosis ≥ 10% Exclusion Criteria: * Familial hypercholesterolemia * Prior history of percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) * Prior history of myocardial infarction before the recent event * Severe liver or renal insufficiency
Contact & Investigator
Ruiyan Zhang, M.D., Ph.D.
PRINCIPAL INVESTIGATOR
Ruijin Hospital
Frequently Asked Questions
Who can join the NCT05884008 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05884008 currently recruiting?
Yes, NCT05884008 is actively recruiting participants. Contact the research team at xiaoqun_wang@hotmail.com for enrollment information.
Where is the NCT05884008 trial being conducted?
This trial is being conducted at Cangzhou, China, Harbin, China, Zhengzhou, China, Wuhan, China and 5 additional locations.
Who is sponsoring the NCT05884008 clinical trial?
NCT05884008 is sponsored by Ruijin Hospital. The principal investigator is Ruiyan Zhang, M.D., Ph.D. at Ruijin Hospital. The trial plans to enroll 300 participants.